ALICE LOUIETTA KING ARNP NPI 1922035906

NPI Details

Alice Louietta King, ARNP is a nurse practitioner in Englewood, FL with 29 years of experience. The provider is (1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners. Alice Louietta King, ARNP NPI is 1922035906. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

3000 S MCCALL RD
ENGLEWOOD, FL
ZIP 34224-616
Phone: (941) 406-9029
Fax: (941) 406-9028

The NPI 1922035906 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Urinalysis, manual test (HCPCS:81002)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Bacterial colony count, urine (HCPCS:87086)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Amylase (enzyme) level (HCPCS:82150)
• Lipase (fat enzyme) level (HCPCS:83690)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Magnesium level (HCPCS:83735)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Administration of vaccine (HCPCS:90471)
• Diphtheria and tetanus vaccine (7 years or older) (HCPCS:90714)
• Automated urinalysis test (HCPCS:81003)

The enumeration date for this NPI number is 6/27/2006 and was last updated on 9/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.